Paid Clinical Trials for Prostate Cancer

Showing 21 – 40 of 221 results

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

by CTG

in Prostate Cancer

Other

California

Deadline:

03/21/2032

PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer

by CTG

in Prostate Cancer, Advanced Urothelial Carcinoma, Genitourinary Cancer, Advanced Renal Cell Carcinoma

Other

California

Deadline:

03/31/2027

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

by CTG

in Prostate Cancer, Prostate Adenocarcinoma, Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Neoplasm

Other

New Jersey

Deadline:

07/01/2026

Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance

by CTG

in Prostate Cancer, Hypogonadism, Male

Other

Florida

Deadline:

02/01/2032

Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment

by CTG

in Prostate Cancer

Other

California

Deadline:

12/16/2036

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

by CTG

in Prostate Cancer, Metastatic Prostate Cancer, Non-metastatic Prostate Cancer

Other

Massachusetts

Deadline:

06/01/2026

Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer

by CTG

in Prostate Cancer

Other

Texas

Deadline:

12/01/2030

DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer

by CTG

in Breast Cancer, Prostate Cancer, Cancer, Financial Toxicity, Question Prompt List

Other

Michigan

Deadline:

08/31/2028

Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy

by CTG

in Prostate Cancer, Prostate Neoplasm

Other

Missouri

Deadline:

02/28/2029

Stratagen Quantitative Prostate MRI Platform Pilot Study

by CTG

in Prostate Cancer

Other

New York

Deadline:

10/31/2026

The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study

by CTG

in Prostate Cancer

Other

Pennsylvania

Deadline:

08/01/2026

Pilot Study of (MR) Imaging with Pyruvate (13C) to Detect High Grade Prostate Cancer

by CTG

in Prostate Cancer, Localized Prostate Carcinoma

Other

California

Deadline:

12/31/2026

Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

by CTG

in Prostate Cancer, Prostate Adenocarcinoma

Other

Ohio

Deadline:

07/01/2028

iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer

by CTG

in Prostate Cancer

Other

Texas

Deadline:

03/28/2028

Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer

by CTG

in Prostate Cancer

Other

District of Columbia

Deadline:

12/01/2026

Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

by CTG

in Prostate Cancer

Other

Oklahoma

Deadline:

06/30/2029

Active Surveillance for Cancer of the Prostate (ASCaP)

by CTG

in Prostate Cancer

Other

California

Deadline:

12/01/2028

CyberKnife Dose Escalation Prostate Cancer Trial

by CTG

in Prostate Cancer, Prostate Adenocarcinoma, Prostate Neoplasm

Other

Pennsylvania

Deadline:

07/12/2028

WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy

by CTG

in Prostate Cancer

Other

California

Deadline:

12/01/2026

Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)

by CTG

in Prostate Cancer

Other

Florida

Deadline:

05/01/2026

Load more All clinical trials loaded.

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance

Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer

DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer

Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy

Stratagen Quantitative Prostate MRI Platform Pilot Study

The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study

Pilot Study of (MR) Imaging with Pyruvate (13C) to Detect High Grade Prostate Cancer

Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer

Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

Active Surveillance for Cancer of the Prostate (ASCaP)

CyberKnife Dose Escalation Prostate Cancer Trial

WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy

Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Prostate Cancer

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps